Menu Close

News & Events

Lazarex news icon
< Timeline >
March 11, 2020
Among the flurry of bills signed into law by Gov. Tony Evers last week, one that didn’t get much attention stands to help cancer patients and their families throughout Wisconsin. The bill, SB 489, passed on voice votes in both the Assembly and Senate with full bipartisan support, addresses economic barriers faced by cancer patients to participate in life-sustaining clinical trials.
Read the article
February 26, 2020
Lazarex Cancer Foundation and Perthera unite to advance Clinical Trial Access and Enrollment for Cancer Patients. They will be focused on matching and enrolling patients in clinical trials through Lazarex IMPACT and CARE programs, by utilizing Perthera’s treatment-matching Artificial Intelligence (AI) technology and other elements of the Perthera Platform to advance precision medicine for cancer patients.
Read the Article
February 26, 2020
The Ritz Herald: llinois Lawmakers announce a new law that will help thousands of cancer patients in the state. SB1711, the Clinical Trial Participation Act gives all Illinois cancer patients new hope by providing access to potentially life-saving breakthrough medical advancements in clinical trials.
Read the Article
February 24, 2020
Major Victory For Cancer Patients In Illinois: Illinois Lawmakers announce a new law that will help thousands of cancer patients in the state. SB1711, the Clinical Trial Participation Act gives all Illinois cancer patients new hope by providing access to potentially life-saving breakthrough medical advancements in clinical trials.
Read the Article
February 24, 2020
NBC 5 Chicago: Clinical trials can save the lives of cancer patients, but studies show minorities and the poor often don’t participate, because they simply can’t afford to. Parking costs and travel expenses add up, but a new law in Illinois allows patients to get reimbursed for those expenses. Includes interview with Lazarex Cancer Foundation’s Dana Dornsife.
Watch the Video
February 24, 2020
WTTW PBS Chicago Tonight interview with Dana Dornsife, Founder of Lazarex Cancer Foundation; Dr. Leon Platanias, Director of the Northwestern University Robert H. Lurie Comprehensive Cancer Center; and Theresa Staten, who has been participating in a clinical drug trial with assistance from Lazarex Cancer Foundation, about The Cancer Clinical Trial Participation Act, Senate Bill 1711, recently signed into law.
Watch the Interview
February 24, 2020
Chicago Tribune: New law will provide Illinois cancer patients funds to attend clinical trials: The Clinical Trial Participation Act was formally announced Wednesday. The legislation, which was signed Dec. 20, aims to increase participation in clinical trials by removing primary barriers for patients, a big one being finances.
Read the Article
February 7, 2020
Danville, CA Nonprofit Helps Patients Find Trials: KRON SF’s Terisa Estacio interviews Erin Miller of Lazarex Cancer Foundation about the foundation’s mission to help patients find and participate in FDA cancer clinical trials. #CancerPreventionMonth
Watch the Interview
February 5, 2020
All men are not created equal in the world of cancer. That is one message from Hala Borno, MD, PhD, a medical oncologist focusing on genitourinary malignancies at the UCSF Helen Diller Family Comprehensive Cancer Center. “I have a research interest in addressing disparities, the reflection of differences that lead to inequity,” she told Oncology Times.
Read the Article
January 30, 2020
Greenphire, the global leader in financial software for clinical trials, today announced that its CEO, Jim Murphy, will co-present alongside Lazarex Cancer Foundation Founder, Dana Dornsife, at the Society for Clinical Research Sites (SCRS)’s annual Global Oncology Site Solutions Summit.
Read the Article
< Timeline >
December 16, 2019
Chicago’s WGN Radio 720 interview with Dana Dornsife and Lazarex patient Theresa Staten Host Anna Daviantes talks clinical trials, Lazarex programs and recent efforts to get a bill in Illinois signed into law. Forward to 59:08 to hear the Lazarex interview.
Learn More
December 5, 2019
Lazarex Cancer Foundation receives Danville Community Service Award. Founder Dana Dornsife accepts the award.
Learn More
November 13, 2019
NCCS Presents 4th Annual Ellen L. Stovall Award to Dr. Harmar Brereton and Dana Dornsife for Their Innovation and Dedication to Cancer Survivors Congressman Mark DeSaulnier (CA-11), a cancer survivor, presented the award to his constituent, Mrs. Dornsife. View the video honoring Dana Dornsife, Cancer Advocacy Innovator, at the award ceremony.
Learn More
November 3, 2019
Tri-Valley Hero: Danville’s Dana Dornsife, improving access to clinical trials The Pleasanton Weekly honors Lazarex Cancer Foundation’s Founder and Board Chair Dana Dornsife with the Role Model award at the Tri-Valley Heroes Awards Ceremony
Learn More
October 30, 2019
Lazarex Cancer Foundation is featured on PBS Newshour: Why minority representation in medical research is a matter of life and death. The country’s diversity is becoming ever greater, but medical research that could benefit the populace is not keeping pace. Special correspondent Cat Wise has the story.
Learn More
October 8, 2019
Cancer patients often need this one basic thing to participate in clinical trials The Philadelphia Inquirer’s Marie McCollough interviews Lazarex Cancer Foundation Founder Dana Dornsife about the foundations’s initiatives in Philadelphia.
Learn More
September 30, 2019
Wrapping Up the Lazarex Gala – Lazarex Cancer Foundation’s “Treasure the Moments” gala was a memorable evening for everyone who attended. With a full house of more than 200 guests, the event raised $291,980 (net) due to very generous and spirited giving! Read the RECAP here. Check out gala photos here.
Learn More
September 21, 2019
Lazarex Gala “Treasure the Moments” – Join us at Garré Vineyard & Winery in Livermore, CA .
Learn More
September 12, 2019
Lazarex Cancer Foundation’s founder Dana Dornsife receives Diablo Magazine’s “Agents of Change” Award. View photos here.
Learn More
September 5, 2019
Lazarex Development Manager Erin Miller sits down with AMGEN and The Washington Post Live to discuss IMPACT and clinical trials. Content from Amgen Oncology: Accelerating Discovery
Learn More
August 2019
Newsletter
Learn More
August 27, 2019
New Texas law will help cover some costs for cancer treatment patients Lazarex VIP (Very Important Patient) Charmaine Sarpong and Founder Dana Dornsife speak with Fox 4 Dallas reporter Dionne Anglin about the legislation in Texas that is effective 9/1 and will help 10’s of thousands of the state’s cancer patients gain access to clinical trials.
Learn More
August 23, 2019
Diablo Magazine Announces its 2019 AGENTS of CHANGE, 23 innovators, movers and shakers, and groundbreakers who are blazing trails in the East Bay and beyond. Dana Dornsife is among the honorees to be recognized at a reception on September 12, 2019.
Learn More
August 7, 2019
NCCS Announces 2019 Stovall Award Honorees, Dr. Harmar Brereton and Dana Dornsife. Read the press release here.
Learn More
August 6, 2019
Lazarex Cancer Foundation founder Dana Dornsife talks with Ann Pietrangelo about the costs associated with clinical trials.
Learn More
July 30, 2019
Founding IMPACT sponsor, AMGEN, welcomes Lazarex Cancer Foundation’s Dana Dornsife to their headquarters campus.
Learn More
June 2019
Newsletter
Learn More
June 19, 2019
Dana Dornsife, the founder of one such organization, called the Lazarex Cancer Foundation, spoke on Good Day DC yesterday morning about how these financial barriers are “the cancer problem that no one’s talking about.”
Learn More
June 18, 2019
Lazarex Cancer Foundation hosted some of the biggest disruptors and innovators in oncology, patient advocacy and public policy to discuss making cancer research more accessible to ALL patients. View the video here. View the RECAP here.
Learn More
June 18, 2019
FOX 5’s Holly Morris sits down with Jackie Hinckley, a patient being helped by the Lazarex Cancer Foundation, and founder, Dana Dornsife.
Learn More
June 18, 2019
Lazarex Cancer Foundation applauds Texas lawmakers for passing a law to break barriers to cancer clinical trials and provide equal access to potentially life-saving breakthrough medical advancements.
Learn More
June 11, 2019
Cancer robbed Ellie of her hair but not her life. She is now 8 and a survivor. Lazarex Cancer Foundation helps Ellie’s family with travel expenses for trips to New York for her treatment.
Learn More
June 5, 2019
Building trust is key to improving diversity in clinical trials. At BIO Tuesday, panelists discussed the lack of racial, ethnic and gender diversity in clinical trials and its potential implications… the panel included Lazarex Cancer Foundation founder Dana Dornsife…
Learn More
June 4, 2019
How Cultural Competence Could Help Boost Diversity in Clinical Research – If studies lack diversity, we’ll lack a clear picture of whether a treatment will work in all populations… Dana Dornsife, founder of Lazarex Cancer Foundation, acknowledged that there is no one-size-fits-all solution…
Learn More
June 2019
Overcoming Financial Barriers to Clinical Trials Enrollment – The Coalition for Clinical Trials Awareness hosted a Washington, DC policy panel discussion on May 14 to explore the issue. Laura Evans Manatos of Lazarex Cancer Foundation was one of the four panelists.
Learn More
June 2019
Community, University, Industry Partner to Boost Minority Recruitment – A community-based initiative in West Philadelphia is blazing a trail for minority involvement in cancer trials, and academia and industry are signing on for the ride. See pages 1 & 5.
Learn More
May 30, 2019
USC researchers offer financial aid to increase participation in clinical trials. Researchers depend on a wide variety of people signing up for clinical trials, so they can get the most diverse results. But participating in research can be time-consuming and costly… Lazarex Foundation provides the funding…
Learn More
May 2019
Newsletter
Learn More
May 24, 2019
Drexel and Lazarex Cancer Foundation Establish Program to Help Improve Health Outcomes for Philadelphia Neighborhoods – Drexel University is partnering with the Lazarex Cancer Foundation to establish Community IMPACT, a program that will focus on reducing cancer and …
Learn More
May 23, 2019
Navigating trial enrollment roadblocks for underrepresented populations. Dana Dornsife, founder of Lazarex Cancer Foundation, which is partnering on the IMPACT study, said in a statement, “The potential benefits of clinical …
Learn More
May 22, 2019
Lazarex Foundation Works To Achieve Minority Equity In Cancer Clinical Trials – Clinical Informatics News. The Lazarex Cancer Foundation is working to sustainably achieve minority equity and increased enrollment in cancer clinical trials nationwide by …
Learn More
May 14, 2019
Greenphire partners with Lazarex to ease oncology trial reimbursement. Lazarex partners with Greenphire to implement the latter’s ClinCard reimbursement technology to improve patient participation in oncology trials.
Learn More
May 13, 2019
Greenphire Forms Strategic Partnership with Lazarex Cancer Foundation to Support Its Oncology … Lazarex Cancer Foundation covers the costs for patients seeking to participate in oncology clinical trials, including airfare, ground transportation and …
Learn More
May 4, 2019
In Brief USC and UCSF join Lazarex in IMPACT program to increase diversity in trials. The Cancer Letter Publications USC Norris Comprehensive Cancer Center and UCSF Helen Diller Comprehensive Cancer Center joined a program with Lazarex Cancer Foundation …
Learn More
May 1, 2019
USC Clinical Trials You can start full episode at the top and fast forward to about 22:00 to hear Erin’s interview. The page also has a small blurb about IMPACT if you scroll down.
Learn More
May 1, 2019
Pierde la salud, su hogar y aunque gana una batalla, todavía teme por su familia. Clara Salas siempre había sido una mujer trabajadora e independiente, dedicada a mantener a sus cuatro hijos ya que es madre soltera. No obstante, hace dos años recibió un golpe devastador.
Learn More
April 30, 2019
USC Norris Launches Diversity-Driven Study Among Clinical Trial Participants – She is also the namesake of the USC Dana and David Dornsife College of Letters, Arts and Sciences. “With more than 1.5 million people receiving a …
Learn More
April 29, 2019
USC Norris Launches Breakthrough Program to Increase Diversity in Cancer Clinical Trials – IMPACT (IMproving Patient Access to Cancer Clinical Trials) is a first-of-its-kind program combining financial reimbursement, outreach, and …
Learn More
April 29, 2019
USC Norris launches study to increase diversity among clinical trial participants. She is also the namesake of the USC Dana and David Dornsife College of Letters, Arts and Sciences. “With more than 1.5 million people receiving a …
Learn More
April 26, 2019
Leveraging technology and digital tools to (finally) increase diversity in clinical trials. The nonprofit Lazarex Cancer Foundation is collaborating with University of California, San Francisco on a three-year study to improve cancer clinical …
Learn More
April 2019
Newsletter
Learn More
April 16, 2019
UCSF Study Aims to Increase Diversity in Cancer Clinical Trials – UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial …
Learn More
April 10, 2019
Unique Charity Helps Cancer Patients Find And Access Clinical Trials – The mission of Lazarex Cancer Foundation is to give every person the … A fundraiser, Lazarex Impact 5.44k, is scheduled for April 27, 2019. Basically …
Learn More
March 20, 2019
Sue Hall speaks with members of Lazarex Cancer Foundation helping patients participate in Clinical Trials.
Learn More
February 18, 2019
Executive Provides Mentorship and Promotes Diversity at Genentech – Kenkare-Mitra sits on the board member of the Genentech Foundation, which is one way that she has been able to drive attempts to improve diversity at the Bay Area company.
Learn More
February 2019
Newsletter
Learn More
January 9, 2019
ASCO policy statement targets financial barriers to clinical trial participation – A policy statement issued by ASCO emphasizes the importance of increasing participation in cancer clinical research trials and outlines recommendations to improve access for underserved populations.
Learn More